The S1103Y Cardiac Sodium Channel Variant Is Associated With Implantable Cardioverter-Defibrillator Events in Blacks With Heart Failure and Reduced Ejection Fraction
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Genetics
- Vol. 4 (2) , 163-168
Abstract
Background—: Risk-stratifying heart failure patients for primary prevention implantable cardioverter-defibrillators (ICDs) remains a challenge, especially for blacks, who have an increased incidence of sudden cardiac death but have been underrepresented in clinical trials. We hypothesized that the S1103Y cardiac sodium channel SCN5A variant influences the propensity for ventricular arrhythmias in black patients with heart failure and reduced ejection fraction. Methods and Results—: Blacks (n=112) with ejection fractions P =0.03). Controlling for baseline characteristics, the adjusted hazard ratio using a Cox proportional hazard model for ICD therapy in Y1103 allele carriers was 4.33 (95% confidence interval, 1.60 to 11.73, P =<0.01). There was no difference in mortality between carriers and noncarriers. Conclusions—: This is the first report that the S1103Y variant is associated with a higher incidence of ventricular arrhythmias in blacks with heart failure and reduced ejection fraction.Keywords
This publication has 19 references indexed in Scilit:
- Usefulness of the Duke Sudden Cardiac Death Risk Score for Predicting Sudden Cardiac Death in Patients With Angiographic (>75% Narrowing) Coronary Artery DiseaseThe American Journal of Cardiology, 2009
- A common cardiac sodium channel variant associated with sudden infant death in African Americans, SCN5A S1103YJournal of Clinical Investigation, 2006
- Role of SCN5A Y1102 Polymorphism in Sudden Cardiac Death in BlacksCirculation, 2005
- Comparison of Ventricular Arrhythmia Frequency in Patients With Ischemic Cardiomyopathy Versus Nonischemic Cardiomyopathy Treated With Implantable Cardioverter DefibrillatorsThe American Journal of Cardiology, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-DefibrillatorsCirculation, 2004
- Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac ArrhythmiaScience, 2002
- Representation of the Elderly, Women, and Minorities in Heart Failure Clinical TrialsArchives of internal medicine (1960), 2002
- Shock Reduction Using Antitachycardia Pacing for Spontaneous Rapid Ventricular Tachycardia in Patients With Coronary Artery DiseaseCirculation, 2001
- Ca2+/Calmodulin-Dependent Facilitation and Inactivation of P/Q-Type Ca2+ ChannelsJournal of Neuroscience, 2000